[Federal Register Volume 85, Number 222 (Tuesday, November 17, 2020)]
[Notices]
[Pages 73282-73283]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual 
meeting. The meeting will be open to the public. During this meeting, 
the TBDWG will finalize and vote on the 2020 report to the HHS 
Secretary and Congress. The agenda will be available on the website 
prior to the meeting. The 2020 report will address ongoing tick-borne 
disease research, including research related to causes, prevention, 
treatment, surveillance, diagnosis, diagnostics, and interventions for 
individuals with tick-borne diseases; advances made pursuant to such 
research; Federal activities related to tick-borne diseases; and gaps 
in tick-borne disease research

DATES: The meeting will be held online via webcast on December 2, 2020, 
from approximately 9:00 a.m. to 5:00 p.m. ET (times are tentative and 
subject to change). The confirmed times and agenda items for the 
meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-12-2/index.html 
when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E. Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: [email protected]; 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: Please register for the meeting at https://
events-

[[Page 73283]]

na4.adobeconnect.com/content/connect/c1/841425677/en/events/event/
shared/1840895551/event_landing.html?sco-id=1840508041&_charset_=utf-8. 
After registering, you will receive an email confirmation with a 
personalized link to access the webcast on December 2, 2020.
    The public will have an opportunity to present their views to the 
TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-12-2/index.html and 
respond by midnight November 24, 2020, ET. Verbal comments will be 
limited to three minutes each to accommodate as many speakers as 
possible during the 30 minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review Federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the Federal 
response to tick-borne disease every two years.

    Dated: November 10, 2020.
B. Kaye Hayes,
Acting Director, Office of Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2020-25312 Filed 11-16-20; 8:45 am]
BILLING CODE 4150-28-P